Beijing Tiantan Biological Products Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000WF9
  • SHG: 600161
CNY
12.31
-0.15 (-1.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,453.66
1,141.70
1,702.96
1,336.05
1,774.00
1,304.53
1,958.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,453.66
1,141.70
1,702.96
1,336.05
1,774.00
1,304.53
1,958.50
Raw Material Cost
940.70
773.04
979.61
835.69
1,007.88
736.18
935.06
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.87
1.84
0.00
3.23
1.93
2.40
1.31
Selling and Distribution Expenses
144.79
110.84
164.31
150.64
134.74
152.66
136.27
Other Expenses
2.79
3.44
5.38
4.00
2.15
2.47
3.96
Total Expenditure (Excl Depreciation)
1,115.23
920.07
1,197.75
1,029.54
1,166.10
915.98
1,112.20
Operating Profit (PBDIT) excl Other Income
338.40000000000003
221.6
505.20000000000005
306.5
607.9
388.5
846.3
Other Income
5.91
28.85
4.65
9.43
28.17
21.88
48.61
Operating Profit (PBDIT)
419.76
345.31
589.51
426.44
747.65
522.31
918.68
Interest
1.87
1.84
0.00
3.23
1.93
2.40
1.31
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
512.96
368.67
723.35
500.36
766.13
568.35
1,023.44
Depreciation
120.26
120.26
114.18
114.18
113.63
113.63
94.59
Profit Before Tax
297.63
223.22
475.33
309.03
632.09
406.28
822.78
Tax
62.16
44.12
105.90
54.37
103.57
69.00
137.91
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
173.04
125.87
272.15
186.12
388.42
244.15
497.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
173.04
125.87
272.15
186.12
388.42
244.15
497.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
62.43
53.23
97.27
68.53
140.10
93.14
187.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
235.47
179.09
369.43
254.66
528.52
337.28
684.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,940.01
11,862.65
11,735.17
11,463.05
11,573.53
11,382.85
11,138.70
Earnings per share (EPS)
0.09
0.06
0.14
0.09
0.2
0.12
0.25
Diluted Earnings per share
0.09
0.06
0.14
0.09
0.2
0.12
0.25
Operating Profit Margin (Excl OI)
20.2%
17.19%
27.64%
22.67%
34.15%
29.65%
39.6%
Gross Profit Margin
28.75%
30.08%
34.62%
31.68%
42.04%
39.85%
46.84%
PAT Margin
11.9%
11.02%
15.98%
13.93%
21.89%
18.72%
25.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 27.33% vs -32.96% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 31.49% vs -51.52% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 30.77% vs -45.89% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 5.56% vs 0.00% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Beijing Tiantan Biological Products Corp. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,453.66
0
1,453.66
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,453.66
0
1,453.66
Raw Material Cost
940.70
0
940.70
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.87
0
1.87
Selling and Distribution Expenses
144.79
0
144.79
Other Expenses
2.79
0.00
2.79
Total Expenditure (Excl Depreciation)
1,115.23
0
1,115.23
Operating Profit (PBDIT) excl Other Income
338.44
0.00
338.44
Other Income
5.91
0
5.91
Operating Profit (PBDIT)
419.76
0
419.76
Interest
1.87
0
1.87
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
512.96
0
512.96
Depreciation
120.26
0
120.26
Profit Before Tax
297.63
0
297.63
Tax
62.16
0
62.16
Provisions and contingencies
0
0
0.00
Profit After Tax
173.04
0
173.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
173.04
0
173.04
Share in Profit of Associates
0
0
0.00
Minority Interest
62.43
0
62.43
Other related items
0.00
0.00
0.00
Consolidated Net Profit
235.47
0
235.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,940.01
0
11,940.01
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
20.20%
0%
0.00
20.20%
Gross Profit Margin
28.75%
0%
0.00
28.75%
PAT Margin
11.90%
0%
0.00
11.90%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 145.37 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 27.33% vs -32.96% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -18.06% vs 9.55% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 23.55 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 31.49% vs -51.52% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -55.44% vs -4.48% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.39 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 30.77% vs -45.89% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -42.47% vs -2.20% in Jun 2025

Quarterly - Interest
Interest 0.19 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 5.56% vs 0.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 0.00% vs 35.71% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.20%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Footer loading